Home
Browse
Search
Statistics
About
Usage
PMID: 14662004
Zeitlin PL
Emerging drug treatments for cystic fibrosis.
Expert Opin Emerg Drugs. 2003 Nov;8(2):523-35.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
53
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 14662004:53:55
status:
NEW
view ABCC7 p.Pro574His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 14662004:53:45
status:
NEW
view ABCC7 p.Asn1303Lys details
The ∆F508 mutation and others such as
N1303K
or
P574H
[26], which are also misprocessed in the ER, have been grouped together as Class 2 mutations in CFTR [27].
Login to comment
57
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 14662004:57:38
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 14662004:57:46
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 14662004:57:31
status:
NEW
view ABCC7 p.Gly542* details
Examples in this class include
G542X
,
W1282X
,
R553X
and 621 + 1 G→T.
Login to comment
60
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:60:20
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 14662004:60:30
status:
NEW
view ABCC7 p.Gly551Ser details
This group includes
G551D
and
G551S
.
Login to comment
61
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:61:78
status:
NEW
view ABCC7 p.Gly551Asp details
A lead compound has already been identified that is capable of activating the
G551D
channel to near wild-type levels, offering the greatest hope for pharmacologic correction.
Login to comment
63
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 14662004:63:0
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 14662004:63:7
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 14662004:63:17
status:
NEW
view ABCC7 p.Arg347Pro details
R117H
,
R334W
and
R347P
are examples of mutations that appear to yield a milder clinical phenotype even when in combination with a more severe allele.
Login to comment
66
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 14662004:66:63
status:
NEW
view ABCC7 p.Ala455Glu details
Examples of Class 5 mutations include 3849 + 10 kB C→T,
A455E
or 2789 + 5 G→A.
Login to comment
88
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:88:313
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:88:616
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:88:636
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 14662004:88:383
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 14662004:88:255
status:
NEW
view ABCC7 p.Pro574His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 14662004:88:464
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 14662004:88:107
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 14662004:88:122
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 14662004:88:320
status:
NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 14662004:88:327
status:
NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 14662004:88:335
status:
NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 14662004:88:390
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 14662004:88:397
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 14662004:88:247
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 14662004:88:115
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser1455*
X
ABCC7 p.Ser1455* 14662004:88:531
status:
NEW
view ABCC7 p.Ser1455* details
ABCC7 p.Gln1412Ser
X
ABCC7 p.Gln1412Ser 14662004:88:539
status:
NEW
view ABCC7 p.Gln1412Ser details
Class of mutation Molecular mechanism Pancreatic status (if known) Examples 1 No CFTR protein synthesis PI
W1282X
,
G542X
,
R553X
, 621 + 1 G→T, 1717-1 G→A, 3905insT, 394delTT 2 Abnormal CFTR processing and trafficking PI ∆F508,
N1303K
,
P574H
3 Defective CFTR regulation (normal trafficking) PI
G551D
,
G551S
,
G1349D
,
S1255P
4 Decreased CFTR chloride conductance PS
R117H
,
R334W
,
R347P
, P547H 5 Reduced synthesis and trafficking of normal CFTR PS
A455E
, 3849 + 10kb C→T, (5T) 6A Reduced apical stability PI
S1455X
,
Q1412S
, 4326delTC, 4279insA 6B Defective regulation of other ion channels PI
G551D
Note that the
G551D
is placed in Class 3 for defective regulation and Class 6B for defective regulation of the outwardly rectifying chloride channel.
Login to comment
91
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 14662004:91:23
status:
NEW
view ABCC7 p.Arg117His details
When 5T is in cis with
R117H
, there is further reduction in CFTR function.
Login to comment
117
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:117:128
status:
NEW
view ABCC7 p.Gly551Asp details
Genistein, a tyrosine kinase inhibitor, not only stimulates ∆F508 chloride conductance, but is potent at stimulating the
G551D
mutant [66-70].
Login to comment
206
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:206:114
status:
NEW
view ABCC7 p.Gly551Asp details
Fischer rat thyroid cells stably coexpressing the green fluorescent protein and either wild-type, ∆F508 or
G551D
CFTR were used to screen 60,000 chemically diverse compounds (at 10 µM) for activation of forskolin-mediated chloride efflux [144,145].
Login to comment
301
ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 14662004:301:66
status:
NEW
view ABCC7 p.Pro574His details
OSTEDGAARD LS, ZEIHER B, WELSH MJ: Processing of CFTR bearing the
P574H
mutation differs from wild-type and deltaF508-CFTR.
Login to comment
416
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:416:129
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 14662004:416:130
status:
NEW
view ABCC7 p.Gly551Asp details
69. ILLEK B, ZHANG L, LEWIS NC, MOSS RB, DONG JY, FISCHER H: Defective function of the cystic fibrosis-causing missense mutation
G551D
is recovered by genistein. Am. J. Physiol.
Login to comment